Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis

Clinical Cancer Research

Volumn 14, Issue 7, 2008, Pages 2161-2170

  Vuyyuri, Saleha B ^a   Hamstra, Daniel A ^a   Khanna, Divya ^a   Hamilton, Christin A ^a   Markwart, Sonja M ^a   Campbell, Kathleen C M ^c   Sunkara, Prasad ^b   Ross, Brian D ^a   Rehemtulla, Alnawaz ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Molecular Therapeutics Inc   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXTRO METHIONINE; METHIONINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; HUMAN; HUMAN CELL; IONIZING RADIATION; LIP DISEASE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; ORAL MUCOSAL DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RAT; SINGLE DRUG DOSE; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DNA DAMAGE; FIBROBLASTS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; METHIONINE; MICE; MICE, INBRED C3H; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; RATS; STOMATITIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 42249102303     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1954     Document Type: Article

References (64)

1. Salama JK, Seiwert TY, Vokes EE. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 2007;25:4118-26.
2. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998;34:39-43.
3. Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003;3:405-12.
4. Donnelly JP, Blijlevens NM, Verhagen CA. Can anything be done about oral mucositis?. Ann Oncol 2003;14:505-7.
5. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001;19:2201-5.
6. Shih A, Miaskowski C, Dodd MJ, Stotts NA, MacPhail L. Mechanisms for radiation-induced oral mucositis and the consequences. Cancer Nurs 2003;26:222-9.
7. Scully C, Epstein JB. Oral health care for the cancer patient. Eur J Cancer 1996;32B:281-92.
8. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999;85:2103-13.
9. Sonis ST, Peterson DE, McGuire DB, Williams DA. Prevention of mucositis in cancer patients. J Natl Cancer Inst 2001;29:1-2.
10. Denham JW, Peters LJ, Johansen J, et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?. Radiother Oncol 1999;52:157-64.
11. Bentzen SM, Saunders MI, Dische S, Bond SJ. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 2001;60:123-35.
12. Brizel DM. Pharmacologic approaches to radiation protection. J Clin Oncol 2007;25:4084-9.
13. Allison RR, Vongtama V, Vaughan J, Shin KH. Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest 1995;13:16-22.
14. Foote RL, Loprinzi CL, Frank AR, et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 1994;12:2630-3.
15. Trotti A, Garden A, Warde P, et al. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys 2004;58:674-81.
16. Gordon B, Spadinger A, Hodges E, Ruby E, Stanley R, Coccia P. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J Clin Oncol 1994;12:1917-22.
17. Crawford H, Claspy J, Vincent M, Tomita D, Mazunet R. Effect of figrastim (r-metHug-CSF) on oral mucositis in patients with small cell lung cancer (SCLC) receiving chemotherapy (cyclophosphamide, doxorubicin, and etoposide (CAE)). Annual Meeting of the American Society of Clinical Oncology; 1994. p. A1523.
18. Chi KH, Chen CH, Chan WK, et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 1995;13:2620-8.
19. Cartee L, Petros WP, Rosner GL, et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. Cytokine 1995;7:471-7.
20. Ryu JK, Swann S, LeVeque F, et al. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. Int J Radiat Oncol Biol Phys 2007;67:643-50.
21. Dorr W, Spekl K, Farrell CL. Amelioration of acute oralmucositis by keratinocyte growth factor: fractionated irradiation. Int J Radiat Oncol Biol Phys 2002;54:245-51.
22. Meropol NJ, Somer RA, Gutheil J, et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J Clin Oncol 2003;21:1452-8.
23. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:2590-8.
24. Verdi CJ, Garewal HS, Koenig LM, Vaughn B, Burkhead T. A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:36-42.
25. Osaki T, Ueta E, Yoneda K, Hirota J, Yamamoto T. Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants. Head Neck 1994;16:331-9.
26. Labar B, Mrsic M, Pavletic Z, et al. Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant 1993;11:379-82.
27. Shenep JL, Kalwinsky DK, Hutson PR, et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr 1988;113:758-63.
28. Jebb SA, Osborne RJ, Maughan TS, et al. 5-Fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. Br J Cancer 1994;70:732-5.
29. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
30. Anne PR, Machtay M, Rosenthal DI, et al. A phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2007;67:445-52.
31. Rocke LK, Loprinzi CL, Lee JK, et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer1993;72:2234-8.
32. Cowen D, Tardieu C, Schubert M, et al. Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 1997;38:697-703.
33. Lu SC. Regulation of hepatic glutathione synthesis. Semin Liver Dis 1998;18:331-43.
34. Fernandez-Checa JC, Garcia-Ruiz C, Colell A, et al. Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 1998;8:7-11.
35. Ghibelli L, Fanelli C, Rotilio G, et al. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J 1998;12:479-86.
36. Campbell KC, Meech RP, Klemens JJ, et al. Prevention of noise- and drug-induced hearing loss with D-methionine. Hear Res 2007;226:92-1.
37. 2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs. Hear Res 2005;205:102-9.
38. Kaji H, Niioka T, Kojima Y, Yoshida Y, Kawakami Y. Urinary 3-methylthiopropionate excretion and the effectof D-or L-methionine ingestion studied in healthy subjects. Res Commun Mol Pathol Pharmacol 1987;56:101-9.
39. Kies C, Fox H, Aprahamian S. Comparative value of L- and D-methionine supplementation of an oat-based diet for humans. J Nutr 1975;105:809-14.
40. Stegink LD, Bell EF, Filer LJ, Jr., Ziegler EE, Andersen DW, Seligson FH. Effects of equimolar doses of L-methionine, D-methionine and L-methionine-DL-sulfoxide on plasma and urinary amino acid levels in normal adult humans. J Nutr 1986;116:1185-92.
41. Blom HJ, Boers GH, van den Elzen JP, Gahl WA, Tangerman A. Transamination of methionine in humans. Clin Sci (Lond) 1989;76:43-9.
42. Benevenga NJ. Toxicities of methionine and other amino acids. J Agric Food Chem 1974;22:2-9.
43. Walser M, Lund P, Ruderman NB, Coulter AW. Synthesis of essential amino acids from their α-keto analogues by perfused rat liver and muscle. J Clin Invest 1973;52:2865-77.
44. Stekol JA, Szaran J. Pathological effects of excessive methionine in the diet of growing rats. J Nutr 1962;77:81-90.
45. Friedman M. Chemistry, nutrition, and microbiology of D-amino acids. J Agric Food Chem 1999;47:3457-79.
46. Printen KJ, Brummel MC, Cho E, Stegink LD. Utilization of D-methionine during total parenteral nutrition in post surgical patients. Am J Clin Nutr 1979;32:1200-5.
47. WHO model list of essential medicines; 1988. Report no. 770.
48. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 1997;272:25783-6.
49. Fertil B, Dertinger H, Courdi A, Malaise EP. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 1984;99:73-84.
50. Hamstra DA, Bhojani MS, Griffin LB, Laxman B, Ross BD, Rehemtulla A. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res 2006;66:7482-9.
51. Xu FX, van der Schueren E, Ang KK. Acute reactions of the lip mucosa of mice to fractionated irradiations. Radiother Oncol 1984;1:369-74.
52. Hamstra DA, Lee KC, Tychewicz JM, et al. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther 2004;10:916-28.
53. Campbell KC, Meech RP, Rybak LP, Hughes LF. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 1999;138:13-28.
54. Campbell KC, Meech RP, Rybak LP, Hughes LF. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J Am Acad Audiol 2003;14:144-56.
55. Campbell KC, Rybak LP, Meech RP, Hughes L. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996;102:90-8.
56. Taneja N, Tjalkens R, Philbert MA, Rehemtulla A. Irradiation of mitochondria initiates apoptosis in a cell free system. Oncogene 2001;20:167-77.
57. Fields MT, Eisbruch A, Normolle D, et al. Radiosensitization produced in vivo by once- vs. twice-weekly 2′2′-difluoro-2′- deoxycytidine (gemcitabine). Int J Radiat Oncol Biol Phys 2000;47:785-91.
58. Scalliet P, Landuyt W, van der Schueren E. Effect of decreasing the dose rate of irradiation on the mouse lip mucosa. Comparison with fractionated irradiations. Radiother Oncol 1987;10:39-47.
59. Unnikrishnan MK, Rao MN. Antiinflammatory activity of methionine, methionine sulfoxide and methionine sulfone. Agents Actions 1990;31:110-2.
60. Bairati I, Meyer F, Gelinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 2005;23:5805-13.
61. Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006;119:2221-4.
62. Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97:481-8.
63. Roscioli N, Kari G, Booty JO, et al. In vivo evaluation of radioprotection by MRX-1024 using a zebrafish model. Annual Meeting of the American Society of Therapeutic Radiology and Oncology (ASTRO), Philadelphia, PA; 2006.
64. Baker DH. Utilization of precursors for L-amino acids. In: D'Mello JPF, editor. Amino acids in farm animal nutrition. London: CAB International; 1994. p. 37-63.